UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038929
Receipt number R000044393
Scientific Title Investigation of the clinical significances and the pathological features of the lanthanum deposition at the gastric mucosa
Date of disclosure of the study information 2019/12/20
Last modified on 2020/11/19 22:21:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the clinical significances and the pathological features of the lanthanum deposition at the gastric mucosa

Acronym

The pathological significance of gastric lanmthanum deposition

Scientific Title

Investigation of the clinical significances and the pathological features of the lanthanum deposition at the gastric mucosa

Scientific Title:Acronym

The pathological significance of gastric lanmthanum deposition

Region

Japan


Condition

Condition

patients on hemodialysis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the lanthanum deposition at gastric mucosa

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Analysis of the clinical significances to compare the clinical feature of the LaC-users with and without La-deposition from endoscopic biopsy specimen from gastric mucosa

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients on hemodialysis taking Lanthanum Carbonate

Key exclusion criteria

none

Target sample size

42


Research contact person

Name of lead principal investigator

1st name Toshihisa
Middle name
Last name Takeuchi

Organization

Osaka medical college hospital

Division name

Endoscopy Center

Zip code

569-8686

Address

2-7, Daigaku-machi, Takatsuki

TEL

072-683-1221

Email

in2097@osaka-med.ac.jp


Public contact

Name of contact person

1st name Kazuhiro
Middle name
Last name Ota

Organization

Osaka medical college

Division name

Second department of internal medicine

Zip code

569-8686

Address

2-7, Daigaku-machi, Takatsuki

TEL

072-683-1221

Homepage URL


Email

clash_kaz@yathoo.co.jp


Sponsor or person

Institute

Osaka medical college

Institute

Department

Personal name



Funding Source

Organization

Osaka medical college

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Moriguchi Keijinkai Hospital

Address

1-47-12, Yakumohigashi-cho, Moriguchi, Osaka

Tel

06-6906-9191

Email

shinya-nishida0608@live.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 12 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

42

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 04 Month 01 Day

Date of IRB

2019 Year 04 Month 05 Day

Anticipated trial start date

2019 Year 12 Month 19 Day

Last follow-up date

2019 Year 12 Month 19 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Original article was accepted.


Management information

Registered date

2019 Year 12 Month 19 Day

Last modified on

2020 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044393


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name